Cargando…

Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma

BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Driemel, Oliver, Müller-Richter, Urs DA, Hakim, Samer G, Bauer, Richard, Berndt, Alexander, Kleinheinz, Johannes, Reichert, Torsten E, Kosmehl, Hartwig
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515303/
https://www.ncbi.nlm.nih.gov/pubmed/18671846
http://dx.doi.org/10.1186/1746-160X-4-17
_version_ 1782158409539256320
author Driemel, Oliver
Müller-Richter, Urs DA
Hakim, Samer G
Bauer, Richard
Berndt, Alexander
Kleinheinz, Johannes
Reichert, Torsten E
Kosmehl, Hartwig
author_facet Driemel, Oliver
Müller-Richter, Urs DA
Hakim, Samer G
Bauer, Richard
Berndt, Alexander
Kleinheinz, Johannes
Reichert, Torsten E
Kosmehl, Hartwig
author_sort Driemel, Oliver
collection PubMed
description BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the eruptive intraoral growth-pattern, age-peak, unfavourable prognosis and slit-like intratumorous spaces in common histological staining as identical clinical and histopathological features. Immunohistochemical staining for pancytokeratin, cytokeratin, collagen type IV, γ2-chain of laminin-5, endothelial differentiation marker CD31 and CD34, F VIII-associated antigen, Ki 67-antigen, β-catenin, E-cadherin, α-smooth-muscle-actin and Fli-1 were done. RESULTS: Cytokeratin-immunoreactive cells can be identified in both lesions. The large vascularization of ASCC complicates the interpretation of vascular differential markers being characteristic for angiosarcoma. Loss of cell-cell-adhesion, monitored by loss of E-cadherin and β-catenin membrane-staining, are indetified as reasons for massive expression of invasion-factor ln-5 in ASCC and considered responsible for unfavourable prognosis of ASCC. Expression of Fli-1 in angiosarcoma and cellular immunoreaction for ln-5 in ASCC are worked out as distinguishing features of both entities. CONCLUSION: Fli-1 in angiosarcoma and ln-5 in ASCC are distinguishing features.
format Text
id pubmed-2515303
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25153032008-08-13 Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma Driemel, Oliver Müller-Richter, Urs DA Hakim, Samer G Bauer, Richard Berndt, Alexander Kleinheinz, Johannes Reichert, Torsten E Kosmehl, Hartwig Head Face Med Research BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the eruptive intraoral growth-pattern, age-peak, unfavourable prognosis and slit-like intratumorous spaces in common histological staining as identical clinical and histopathological features. Immunohistochemical staining for pancytokeratin, cytokeratin, collagen type IV, γ2-chain of laminin-5, endothelial differentiation marker CD31 and CD34, F VIII-associated antigen, Ki 67-antigen, β-catenin, E-cadherin, α-smooth-muscle-actin and Fli-1 were done. RESULTS: Cytokeratin-immunoreactive cells can be identified in both lesions. The large vascularization of ASCC complicates the interpretation of vascular differential markers being characteristic for angiosarcoma. Loss of cell-cell-adhesion, monitored by loss of E-cadherin and β-catenin membrane-staining, are indetified as reasons for massive expression of invasion-factor ln-5 in ASCC and considered responsible for unfavourable prognosis of ASCC. Expression of Fli-1 in angiosarcoma and cellular immunoreaction for ln-5 in ASCC are worked out as distinguishing features of both entities. CONCLUSION: Fli-1 in angiosarcoma and ln-5 in ASCC are distinguishing features. BioMed Central 2008-07-31 /pmc/articles/PMC2515303/ /pubmed/18671846 http://dx.doi.org/10.1186/1746-160X-4-17 Text en Copyright © 2008 Driemel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Driemel, Oliver
Müller-Richter, Urs DA
Hakim, Samer G
Bauer, Richard
Berndt, Alexander
Kleinheinz, Johannes
Reichert, Torsten E
Kosmehl, Hartwig
Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title_full Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title_fullStr Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title_full_unstemmed Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title_short Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
title_sort oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515303/
https://www.ncbi.nlm.nih.gov/pubmed/18671846
http://dx.doi.org/10.1186/1746-160X-4-17
work_keys_str_mv AT driemeloliver oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT mullerrichterursda oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT hakimsamerg oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT bauerrichard oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT berndtalexander oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT kleinheinzjohannes oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT reicherttorstene oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma
AT kosmehlhartwig oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma